Childress Capital Advisors, LLC Bristol Myers Squibb CO Transaction History
Childress Capital Advisors, LLC
- $352 Million
- Q4 2024
A detailed history of Childress Capital Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Childress Capital Advisors, LLC holds 7,018 shares of BMY stock, worth $431,677. This represents 0.11% of its overall portfolio holdings.
Number of Shares
7,018
Previous 5,967
17.61%
Holding current value
$431,677
Previous $308,000
28.57%
% of portfolio
0.11%
Previous 0.08%
Shares
13 transactions
Others Institutions Holding BMY
# of Institutions
2,761Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$11.7 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.76 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.91 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.85 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.71 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $131B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...